Bio-techne corp TECH.US 總覽分析
)TECH 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面獲得最高評分，股利評分不錯，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
TECH 近期報酬表現
-1.14%
Bio-techne corp
-0.35%
同產業平均
-0.67%
S&P500
與 TECH 同產業的標的表現
- RVTY Revvity inc價值 5 分趨勢 1 分波段 2 分籌碼 5 分股利 3 分查看更多
TECH 公司資訊
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.